Abstract
Diagnosis and treatment of prostate cancer has improved in the last few years, in part due to a multidisciplinary approach between urologists, oncologists, radiotherapists, radiologists, pathologists, basic and translational researchers for a successful management. The TAX 327 study is the paradigm of a smooth communication between expert physicians that led to the approval of docetaxel in metastatic hormone-resistant prostate cancer (HRPC). Survival benefit with docetaxel in HRPC was confirmed in an updated survival analysis reported this year. A nomogram to predict survival in metastatic HRPC treated with chemotherapy was established based on the TAX 327 study. Unfortunately in early prostate cancer, some of the phase III clinical trials with chemotherapy had to be closed due to lack of sufficient accrual, due to, at least in part, an unsuccessful collaboration between urologists, medical oncologists and radiotherapists. In earlier phases of prostate cancer, a successful multidisciplinary approach has led to important advances in genomics, biomarkers and imaging techniques that have created big excitement for future improvements in the management of prostate cancer. An example is the validation of novel molecular diagnosis te...Continue Reading
References
Mar 20, 2003·Current Drug Targets·Martin GleaveKim Chi
Oct 8, 2004·The New England Journal of Medicine·Ian F TannockUNKNOWN TAX 327 Investigators
Mar 2, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Susan GoodinRobert S DiPaola
Mar 2, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael A Carducci
Oct 29, 2005·Science·Scott A TomlinsArul M Chinnaiyan
Nov 8, 2005·Cancer Chemotherapy and Pharmacology·Martin GleaveKim Chi
Mar 10, 2006·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L Mileshkin, J Zalcberg
Apr 22, 2006·Clinical Chemistry·Jack GroskopfHarry Rittenhouse
Feb 10, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Martijn P M Q van GilsJack A Schalken
Mar 27, 2007·Urology·Leonard S MarksJack Groskopf
Apr 18, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A OttaianoM Caraglia
Sep 6, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Daphne HesselsJack A Schalken
Oct 13, 2007·Cancer·Hiroyuki NakanishiR Joseph Babaian
Nov 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Andrew J ArmstrongMario Eisenberger
Dec 14, 2007·Proceedings of the National Academy of Sciences of the United States of America·Ultan McDermottJeffrey Settleman
Dec 15, 2007·Genes & Development·Sreenath V Sharma, Jeffrey Settleman
Jan 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dominik R BertholdIan F Tannock
Feb 5, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kim N ChiElizabeth Eisenhauer
Citations
Aug 31, 2011·Molecular & Cellular Proteomics : MCP·Chen ShaoYouhe Gao
Nov 1, 2011·Journal of Psychosocial Oncology·Nora B HenriksonDonna L Berry
Jul 28, 2011·Cancer Management and Research·Nicole M Engel-NitzFaith Nathan
May 2, 2016·Health Policy·Yueh-Han HsuWen-Chen Tsai
Nov 27, 2014·Journal of Oncology Practice·Sarah C ReedLarissa Nekhlyudov
Feb 7, 2012·Urologia·Alessandro SciarraValeria Panebianco
Oct 5, 2011·Acta Radiologica·Mi-hyun KimKyoung-Sik Cho